NM_001909.5:c.828-17G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001909.5(CTSD):c.828-17G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.069 in 1,604,836 control chromosomes in the GnomAD database, including 4,220 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.055 ( 272 hom., cov: 33)
Exomes 𝑓: 0.070 ( 3948 hom. )
Consequence
CTSD
NM_001909.5 intron
NM_001909.5 intron
Scores
1
14
Clinical Significance
Conservation
PhyloP100: -3.09
Publications
7 publications found
Genes affected
CTSD (HGNC:2529): (cathepsin D) This gene encodes a member of the A1 family of peptidases. The encoded preproprotein is proteolytically processed to generate multiple protein products. These products include the cathepsin D light and heavy chains, which heterodimerize to form the mature enzyme. This enzyme exhibits pepsin-like activity and plays a role in protein turnover and in the proteolytic activation of hormones and growth factors. Mutations in this gene play a causal role in neuronal ceroid lipofuscinosis-10 and may be involved in the pathogenesis of several other diseases, including breast cancer and possibly Alzheimer's disease. [provided by RefSeq, Nov 2015]
CTSD Gene-Disease associations (from GenCC):
- neuronal ceroid lipofuscinosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- neuronal ceroid lipofuscinosis 10Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0028076768).
BP6
Variant 11-1754155-C-T is Benign according to our data. Variant chr11-1754155-C-T is described in ClinVar as Benign. ClinVar VariationId is 258490.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0814 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CTSD | ENST00000236671.7 | c.828-17G>A | intron_variant | Intron 6 of 8 | 1 | NM_001909.5 | ENSP00000236671.2 | |||
| ENSG00000250644 | ENST00000636615.1 | c.828-17G>A | intron_variant | Intron 6 of 9 | 5 | ENSP00000490014.1 |
Frequencies
GnomAD3 genomes AF: 0.0550 AC: 8372AN: 152104Hom.: 271 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
8372
AN:
152104
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0636 AC: 14967AN: 235162 AF XY: 0.0674 show subpopulations
GnomAD2 exomes
AF:
AC:
14967
AN:
235162
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0705 AC: 102338AN: 1452614Hom.: 3948 Cov.: 37 AF XY: 0.0714 AC XY: 51633AN XY: 722702 show subpopulations
GnomAD4 exome
AF:
AC:
102338
AN:
1452614
Hom.:
Cov.:
37
AF XY:
AC XY:
51633
AN XY:
722702
show subpopulations
African (AFR)
AF:
AC:
779
AN:
33404
American (AMR)
AF:
AC:
1938
AN:
44492
Ashkenazi Jewish (ASJ)
AF:
AC:
2319
AN:
26060
East Asian (EAS)
AF:
AC:
1015
AN:
39560
South Asian (SAS)
AF:
AC:
8028
AN:
85810
European-Finnish (FIN)
AF:
AC:
2171
AN:
46826
Middle Eastern (MID)
AF:
AC:
640
AN:
5724
European-Non Finnish (NFE)
AF:
AC:
81062
AN:
1110610
Other (OTH)
AF:
AC:
4386
AN:
60128
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
5129
10258
15388
20517
25646
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3018
6036
9054
12072
15090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0550 AC: 8367AN: 152222Hom.: 272 Cov.: 33 AF XY: 0.0539 AC XY: 4007AN XY: 74400 show subpopulations
GnomAD4 genome
AF:
AC:
8367
AN:
152222
Hom.:
Cov.:
33
AF XY:
AC XY:
4007
AN XY:
74400
show subpopulations
African (AFR)
AF:
AC:
1019
AN:
41564
American (AMR)
AF:
AC:
938
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
313
AN:
3470
East Asian (EAS)
AF:
AC:
148
AN:
5142
South Asian (SAS)
AF:
AC:
426
AN:
4826
European-Finnish (FIN)
AF:
AC:
448
AN:
10622
Middle Eastern (MID)
AF:
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4870
AN:
67976
Other (OTH)
AF:
AC:
152
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
392
784
1176
1568
1960
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
257
ALSPAC
AF:
AC:
281
ESP6500AA
AF:
AC:
109
ESP6500EA
AF:
AC:
596
ExAC
AF:
AC:
7416
Asia WGS
AF:
AC:
272
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Dec 15, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Neuronal ceroid lipofuscinosis 10 Benign:2
Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Sep 21, 2016
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Neuronal ceroid lipofuscinosis Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
PhyloP100
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Benign
T
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.